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Abstract
Background: Pregnancy-associated stroke is a rare but life-threatening event, with an estimated incidence of 30/
100000 deliveries. Data on the risk of stroke recurrence and the risk of other adverse pregnancy outcomes are
essential for adequate counselling and surveillance in subsequent pregnancies. The aim of this systematic review is
to describe the implications of a pregnancy-associated stroke for the future health of these women.
Methods: We searched Ovid Medline, PubMed, Cochrane Library and CINAHL for articles published in 1980–2018.
Articles including women with pregnancy-associated stroke and information on at least one of the following
outcomes were included: 1) recurrence of stroke during subsequent pregnancy, 2) number and course of
subsequent pregnancies and their outcomes and 3) subsequent cardiovascular health.
Results: Twelve articles were included in the review, with six providing information on subsequent pregnancies,
four on subsequent maternal health and two on both. The included articles varied greatly in terms of study design,
length of follow up and reported outcomes. We found 252 women with pregnancy-associated stroke for whom the
outcomes of interest were reported: 135 women with information on subsequent pregnancies and 123 women
with information on future health. In total, 55 pregnancies after stroke were found. In the majority of studies, the
incidence of pregnancy complications was comparable to that of the general population. The risk of stroke
recurrence during pregnancy was 2%. Data on subsequent health of these women were limited, and the quality of
the data varied between the studies.
Conclusions: Data on subsequent pregnancies and health of women with a history of pregnancy-associated stroke
are limited. Further research on this topic is essential for adequate counselling and secondary prevention.
Keywords: Stroke, Pregnancy, Postpartum period, Puerperium, Pregnancy-associated stroke, Follow-up, Recurrence,
Subsequent pregnancies, Pregnancy outcome, Future health, Cardiovascular disease
Background
A stroke during pregnancy or puerperium is a rare event,
but markedly affects the future life of the woman and her
family. Pregnancy-associated stroke (PAS) accounts for up
to 15% of maternal deaths [1]. The reported incidence of
PAS and the distribution of stroke subtypes, ischaemic
stroke (IS), intracerebral haemorrhage (ICH), subarach-
noid haemorrhage (SAH) and cerebral venous thrombosis
(CVT), varies greatly due to different inclusion criteria
and study designs. A recent meta-analysis reported an in-
cidence of 30 strokes per 100,000 deliveries among all
pregnancies [2]. The incidence of PAS varies depending
on gestational age, with the greatest risk observed during
the third trimester, delivery and the early postpartum
period [3, 4]. The latest studies indicate an increase in the
PAS incidence, primarily as a result of an increase in
hypertensive disorders of pregnancy and cardiac disease in
pregnant women [5, 6].
Pregnancy and postpartum period increase the stroke
risk compared to non-pregnant time. The estimated in-
cidence of stroke during reproductive age is 10–20 per
100,000 person-years [7, 8] and during pregnant and
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puerperal time 34 per 100,000 person-years (assuming
the duration of pregnancy to be 40 weeks and defining
puerperium as 6 weeks postpartum). Underlying diseases
such as prothrombotic conditions, heart disease and
anomalies of cerebral vasculature are risk factors for
stroke also during pregnancy [9–12], while women with
PAS are less likely to have conventional risk factors than
non-pregnant women who suffer a stroke at the same
age [13, 14]. Pregnancy-related increase in stroke risk is
thought to be a result of hemodynamic and coagulation
system changes and pregnancy complications such as
hypertensive disorders of pregnancy [5, 10, 12, 15–17],
infections [9, 10, 12], haemorrhage [10] and fluid and
electrolyte imbalance [10, 12].
The outcome of stroke varies, but full recovery is pos-
sible, particularly in high-income countries. Since these
women are of reproductive age, they often wish to conceive
again. However, there is significant uncertainty surround-
ing the potential risks related to subsequent pregnancies
and data on future health and long-term prognosis of these
women are limited. The aim of this systematic review is to
summarise the current knowledge on the subsequent preg-
nancies and future health of women with PAS and know-
ledge gaps in order to highlight the need for further
research on the topic, essential for adequate counselling,
pregnancy surveillance and secondary prevention through-
out life in the future.
Methods
The literature search was conducted to identify studies
reporting subsequent pregnancy outcomes and future
cardiovascular health among women with a history of PAS
in accordance with the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analysis (PRISMA) guidelines
[18]. Relevant studies were identified covering the period
from January 1980 to September 2018. We searched Ovid
Medline, PubMed, Cochrane Library and CINAHL with
the following terms: “stroke” or “cerebrovascular disorder”
or specific stroke types separately and “pregnancy” or
"postpartum period and “follow-up” or “recurrence” (see
Additional file 1 for detailed search strategy). Reference
lists from relevant articles were assessed in order to
identify additional potential articles. Articles were in-
cluded if they were published in English and included
women with a history of pregnancy-associated or puer-
peral stroke. Of the stroke subtypes, we included IS,
CVT, ICH and SAH. TIA was excluded. Articles were
included if information on at least one of the following
outcomes was provided: 1) recurrence of stroke during
subsequent pregnancy, 2) number of subsequent preg-
nancies and their outcomes, 3) subsequent cardiovascu-
lar health. We excluded case reports and studies that
limited their follow-up to the mortality and neuro-
logical recovery from the initial stroke.
Two authors (LK and PI) screened the titles and ab-
stracts identified through the literature search. If eligibility
remained unclear, the full article was reviewed. Disagree-
ments were resolved through consensus. Data on the
number of women with PAS, the number of women with
PAS who had subsequent pregnancies, the number of
pregnancies and their outcomes and complications, data
on future health and the duration of the follow-up were
extracted from the eligible articles.
Results
Figure 1 shows the flow diagram of the review process.
We screened 615 records, 157 abstracts and 69 full-texts
articles. Fifteen articles included women with PAS but did
not provide sufficient data to identify the outcomes for
the subgroup. All twelve included articles mainly reported
outcomes of women with a history of non-pregnancy as-
sociated stroke (NPAS); only 3–33% of women included
in the cohorts had suffered a PAS. We found no studies
focusing solely on women with PAS. Table 1 shows the
details of the included studies [19–30]. We identified 252
cases with PAS who were included in the follow-up of the
outcomes of interest: 135 women for subsequent pregnan-
cies and 123 women for future health. CVT was the index
event in 103/135 women (76%) for whom subsequent
pregnancies were reported.
Course of subsequent pregnancies
Of the 52 women with a history of PAS, 26 (50%) had
subsequent pregnancies; the studies by Ciron et al. [27]
and Ferro et al. [23] were excluded from this calculation,
as they do not report the number of women with subse-
quent pregnancies. The included studies reported a total
of 55 pregnancies. Outcomes were reported in 42 of
these pregnancies and they were the following: 32 live
births (76%), one foetal death (2%), six miscarriages
(14%) and three induced abortions (7%). Pregnancy com-
plications were reported by all but one study [20]. The
studies included 22 pregnancies that proceeded beyond
22 gestational weeks, i.e. excluding miscarriages and in-
duced abortions. Of these 22 pregnancies, 17 (77%) were
uncomplicated/uneventful, three (13%) were compli-
cated by premature rupture of membranes (< 37 gesta-
tional weeks), one (5%) with pre-eclampsia and one (5%)
with foetal death. All of the complications reported were
from the study by Coppage et al. [21]. The information
on subsequent pregnancies and recurrence of stroke
during pregnancy is presented in Table 2.
Alebeek et al. [28] assessed the occurrence of preg-
nancy complications in women with a history of stroke
(IS or TIA) using the Dutch general population as a con-
trol group. The data for the women with a stroke history
were self-reported and collected by telephone interview
and the data to represent the general population was
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retrieved from the Dutch Perinatal Registry or Dutch
HELLP foundation. The patients and controls were not
matched on common risk factors for stroke and preg-
nancy complications (smoking, thrombophilia, hyperten-
sion, hypertensive disorders of pregnancy). In the
subgroup of 20 women with PAS, 50% had experienced
more than one miscarriage, 5% more than one foetal
death, 25% gestational hypertension, 20% pre-eclampsia,
20% HELLP and 10% gestational diabetes. Substantially
lower rates for the Dutch general population were re-
ported: 13.5, 0.9, 11.7, 0.5, 0.5 and 1.8%, respectively.
The study did not report the timing of the pregnancy
outcomes in relation to the PAS, i.e. whether the compli-
cations occurred during the same pregnancy or not.
PAS recurrence
In the 55 pregnancies among women with a history of
PAS, one (2%) recurrent PAS occurred. This was a first
trimester CVT in a woman with a history of CVT dur-
ing pregnancy, sickle cell disease as an underlying condi-
tion. She used no prophylactic anticoagulant medication
during the pregnancies following the primary CVT. The
pregnancy was terminated. The study of Ciron et al. [27]
did not provide details on the primary or the recurrent
CVT (i.e. the location or extend of CVT or did CVT re-
sult in ischemic or haemorrhagic stroke). In addition,
four articles reporting subsequent health of women after
PAS [19, 22, 28, 30] stated there were no recurrent PAS.
Subsequent health
Table 3 presents information on the subsequent health
of women with PAS. The articles varied greatly in terms
of the diseases, outcomes included in follow-up and out-
comes reported for women with PAS. Often all out-
comes of interest were not specifically reported for
women with PAS. The follow-up time varied from 6
months to 16 years after the index stroke. The initial
type of stroke was not specified in 90/123 women (73%)
whose subsequent health was assessed and reported.
During the follow-up there were altogether three vascu-
lar events, all ISs or TIAs from the study of Alebeek et
al. [28]. The studies reporting long-term mortality
Fig. 1 Flow diagram of the review process
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included 101 women and 10 (10%) of these women died
during the follow-up time up to 16 years, four from car-
diovascular causes and six from other causes. All of
these women were from the same cohort from Gastrich
et al. [26] and had pre-eclampsia in association with the
index stroke.
Discussion
During the past two decades knowledge on the inci-
dence and risk factors of PAS has accumulated. By con-
trast, data on subsequent pregnancies and health of
women with PAS are scattered, incompletely reported
and limited information is available. The systematic re-
view suggests that the incidence of pregnancy complica-
tions is comparable to that reported for women with a
history of stroke (related or not related to pregnancy)
[20, 21, 27, 31]. Miscarriage seems to be as common
among women with PAS as in the general population
[32], but induced abortion is slightly more infrequent
than in the general population [33]. This may reflect
more careful family planning after PAS. One study re-
ported less favourable obstetric prognosis, more severe
pregnancy complications and more miscarriages and
foetal deaths in women with a history of stroke than in
the general population [28]. However, there are several
methodological problems in the study. Most import-
antly, the ascertainment and data collection differed
between the women with PAS and controls and they
were not matched on risk factors for adverse pregnancy
outcomes, such as smoking, hypertension and pro-
thrombotic conditions, which all are also risk factors
for stroke. Therefore, the findings may result from con-
founding risk factors. Also the frequencies of adverse
pregnancy outcomes reported in the Dutch Perinatal
Registry for the general populations are low and pos-
sibly under-reported [28], which may overestimate the
differences between women with a stroke history and
general population.
Based on limited number of published cases, the pro-
portion of women with subsequent pregnancies after PAS
was relatively high, 50%. It is noteworthy that the percent-
age is based on less than half of the women with PAS in-
cluded in the analysis of subsequent pregnancies, since
two studies [23, 27] did not provide the data on number
of women with subsequent pregnancies. This may over-
estimate the pregnancy rate. In previous studies, the pro-
portion of young women with a history of stroke (related
or not related to pregnancy) and subsequent pregnancies
has ranged between 26 and 40% [20, 27, 29, 31, 34]. Lamy
et al. [20] found no difference in the number of subse-
quent pregnancies between women with a history of IS or
CVT and age- and parity-matched controls from the
general population. However, one-third of women with a
history of stroke indicated that they would have wished
for more pregnancies after their stroke and the most com-
mon causes for hesitation were concerns of recurrent
stroke, medical advice against a new pregnancy and re-
sidual disability [20].
We found one recurrent PAS, CVT associated to sickle
cell disease. Even though the number of patients is very
limited, the recurrence of stroke during pregnancy or
puerperium seems to be rare. The same applies to young
stroke patients whose initial strokes have not been preg-
nancy related. The recurrence is mainly limited to
women with underlying haematological diseases (such as
protein C and S deficiency, sickle cell disease, antipho-
spholipid syndrome or systemic lupus erythematosus),
cerebrovascular disease (arteriovenous malformations,
aneurysms or Moyamoya disease) or maternal cardiac
disease [20, 21, 31, 35, 36]. This is exemplified by a study
by Fischer-Betz et al. [35] who reported pregnancy out-
comes and recurrence of stroke during pregnancy for 20
women with antiphospholipid syndrome and a history of
IS or TIA. The possible temporal connection of index
stroke to pregnancy was not reported. Among subse-
quent pregnancies, stroke recurred in 15%, while pre-
eclampsia occurred in 34% of pregnancies and 8.7% of
pregnancies resulted in neonatal death. Further, Soriano
et al. [36] reported similar results in a study of thrombo-
embolic complications of pregnancy and pregnancy out-
comes in 12 women (15 pregnancies) with a history of
stroke (IS, TIA and amaurosis fugax) and an underlying
thrombophilic disorder who used LMWH and aspirin
100 mg until 6 weeks’ postpartum. Five of these 12
women (42%) in the cohort had a history of PAS. Four
patients (33%) in this cohort had recurrent thrombo-
embolic events (1 TIA, 1 amaurosis fugax in two subse-
quent pregnancies, 1 paresthesia of the left arm, 1 deep
venous thrombosis and pulmonary embolism 3 weeks
postpartum after discontinuing the preventive medica-
tion contrary to advice). Pre-eclampsia complicated five
pregnancies (33% of all), leading to preterm delivery in
three pregnancies (20%), of which one at 27 gestational
weeks, resulting in neonatal death (7% of newborns).
Even though the proportion of PAS in this cohort was
only 42%, this may indicate that also PAS women with
an underlying predisposing condition are at greater risk
of recurrent PAS, other thrombotic events and adverse
pregnancy outcomes than women whose index PAS has
been cryptogenic.
The studies reporting subsequent health of women after
PAS differed markedly in terms of settings and outcomes
included in the follow-up. In 73% of the women whose
future health was reported, the stroke subtype was not
specified. During the follow-up ranging from 6months to
16 years, altogether three ISs occurred among 123 women,
i.e. 2% of the women suffered a NPAS. All of these women
were from the same cohort of 20 women with PAS, the
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cumulative 20-year risk being 15.6% when assessing this
cohort separately. Hindfelt et al. [37] found 11% of young
IS survivors suffered a recurrence during the 13- to
26-year follow-up. The difference in their results com-
pared with ours may be explained by a shorter follow-up
time in the studies of our review, but also by a lower
prevalence of traditional stroke risk factors among
PAS women. Regarding mortality, we found a cumula-
tive mortality rate of 10% after a follow-up ranging
from 6 months to 16 years. This is in line with previ-
ous studies on the long-term prognosis of young pa-
tients with IS that have reported a cumulative 2- to
10-year mortality of 10% [38, 39].
This study has a number of limitations. All studies in-
cluded in this review were comprised of mainly women
with a history of stroke that was not associated with
pregnancy, the proportion of PAS varying from 3 to
33%. Analyses were performed and results presented for
the entire cohort instead of separating patients by the
timing of the stroke, making it impossible to extract all
outcomes included in the study for women with PAS
specifically. The information about women with PAS,
their subsequent pregnancies and their outcomes often
had to be retrieved from tables in the articles or even
from the discussion. A good example is the total number
of pregnancies reported in the studies; two studies [20, 24]
did not report miscarriages or induced abortions separ-
ately for women with PAS and Ciron et al. [27] reported
outcomes of pregnancies for only one woman with PAS,
but did not state whether other women with PAS had
pregnancies and what their possible outcomes were.
Therefore, the total number of pregnancies for women
with PAS in the included studies may be more than 55.
Lamy at al. [20] did not report pregnancy complications,
which may underestimate their incidence. The quality of
information varied and was especially scant regarding fu-
ture cardiovascular health. The length of the follow-up
period was insufficient for evaluation of long-term cardio-
vascular outcome and mortality. These gaps in reporting
reflect that women with PAS were not the main focus in
these articles. Altogether, the limited number of cases and
incomplete reporting causes uncertainty for the interpret-
ation of result. However, the results revealed an evident
gap in knowledge that warrants research on this topic,
preferably in a population-based setting and with a suffi-
ciently long follow-up.
Conclusion
PAS is a rare event with potentially devastating conse-
quences for the everyday life of the young family. In the
systematic review of subsequent pregnancies and health of
these women, we found the data to be limited. In the con-
text of published literature, half of women with a history
of PAS have subsequent pregnancies, their outcomes are
generally good and the stroke recurrence rate during sub-
sequent pregnancies is low. This is reassuring when it
comes to counselling women with a desire to conceive.
An increased risk of adverse events and recurrence of PAS
may be related to subsequent pregnancies of women with
underlying diseases such as prothrombotic conditions,
anomalies of cerebral vasculature and chronic heart dis-
ease. According to the results of this review, the prognosis
of future health is similar for women with a history of PAS
and patients with a history of stroke at young age, unre-
lated to pregnancy. However, further research on this
topic is needed to improve pregnancy surveillance, pre-
ventive medication in subsequent pregnancies and sec-
ondary prevention throughout life.
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